KYMR
Price
$44.12
Change
-$1.59 (-3.48%)
Updated
Jun 27 closing price
Capitalization
2.87B
34 days until earnings call
RVMD
Price
$36.91
Change
-$0.57 (-1.52%)
Updated
Jun 27 closing price
Capitalization
6.88B
39 days until earnings call
Interact to see
Advertisement

KYMR vs RVMD

Header iconKYMR vs RVMD Comparison
Open Charts KYMR vs RVMDBanner chart's image
Kymera Therapeutics
Price$44.12
Change-$1.59 (-3.48%)
Volume$3.8M
Capitalization2.87B
Revolution Medicines
Price$36.91
Change-$0.57 (-1.52%)
Volume$26.44M
Capitalization6.88B
KYMR vs RVMD Comparison Chart in %
Loading...
KYMR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RVMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
KYMR vs. RVMD commentary
Jun 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KYMR is a Buy and RVMD is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 29, 2025
Stock price -- (KYMR: $44.12 vs. RVMD: $36.91)
Brand notoriety: KYMR and RVMD are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: KYMR: 394% vs. RVMD: 1056%
Market capitalization -- KYMR: $2.87B vs. RVMD: $6.88B
KYMR [@Biotechnology] is valued at $2.87B. RVMD’s [@Biotechnology] market capitalization is $6.88B. The market cap for tickers in the [@Biotechnology] industry ranges from $299.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KYMR’s FA Score shows that 0 FA rating(s) are green whileRVMD’s FA Score has 0 green FA rating(s).

  • KYMR’s FA Score: 0 green, 5 red.
  • RVMD’s FA Score: 0 green, 5 red.
According to our system of comparison, KYMR is a better buy in the long-term than RVMD.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KYMR’s TA Score shows that 3 TA indicator(s) are bullish while RVMD’s TA Score has 2 bullish TA indicator(s).

  • KYMR’s TA Score: 3 bullish, 4 bearish.
  • RVMD’s TA Score: 2 bullish, 5 bearish.
According to our system of comparison, KYMR is a better buy in the short-term than RVMD.

Price Growth

KYMR (@Biotechnology) experienced а -3.82% price change this week, while RVMD (@Biotechnology) price change was -6.93% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +31.22%, and the average quarterly price growth was +12.91%.

Reported Earning Dates

KYMR is expected to report earnings on Aug 01, 2025.

RVMD is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RVMD($6.88B) has a higher market cap than KYMR($2.87B). KYMR YTD gains are higher at: 9.669 vs. RVMD (-15.615). KYMR has higher annual earnings (EBITDA): -232.67M vs. RVMD (-776.65M). RVMD has more cash in the bank: 2.1B vs. KYMR (463M). KYMR has less debt than RVMD: KYMR (86.3M) vs RVMD (134M). KYMR has higher revenues than RVMD: KYMR (58.9M) vs RVMD (0).
KYMRRVMDKYMR / RVMD
Capitalization2.87B6.88B42%
EBITDA-232.67M-776.65M30%
Gain YTD9.669-15.615-62%
P/E RatioN/AN/A-
Revenue58.9M0-
Total Cash463M2.1B22%
Total Debt86.3M134M64%
TECHNICAL ANALYSIS
Technical Analysis
KYMRRVMD
RSI
ODDS (%)
Bearish Trend 2 days ago
87%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
87%
Momentum
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
82%
MACD
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
83%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
76%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
76%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
77%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
85%
Aroon
ODDS (%)
N/A
N/A
View a ticker or compare two or three
Interact to see
Advertisement
KYMR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RVMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
AULYX103.250.96
+0.94%
American Century Ultra® Y
MEFIX14.280.04
+0.28%
Martin Currie Emerging Markets FI
HSPCX16.320.03
+0.18%
Emerald Growth C
FELAX91.02N/A
N/A
Fidelity Advisor Semiconductors A
ASIRX11.12-0.01
-0.09%
Alger Small Cap Growth Institutional R

KYMR and

Correlation & Price change

A.I.dvisor indicates that over the last year, KYMR has been closely correlated with NRIX. These tickers have moved in lockstep 67% of the time. This A.I.-generated data suggests there is a high statistical probability that if KYMR jumps, then NRIX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KYMR
1D Price
Change %
KYMR100%
-3.48%
NRIX - KYMR
67%
Closely correlated
+0.17%
CCCC - KYMR
64%
Loosely correlated
-7.89%
CGON - KYMR
54%
Loosely correlated
-0.46%
VERA - KYMR
54%
Loosely correlated
-2.83%
RVMD - KYMR
53%
Loosely correlated
-1.52%
More

RVMD and

Correlation & Price change

A.I.dvisor indicates that over the last year, RVMD has been loosely correlated with ERAS. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if RVMD jumps, then ERAS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RVMD
1D Price
Change %
RVMD100%
-1.52%
ERAS - RVMD
57%
Loosely correlated
+3.97%
CRNX - RVMD
55%
Loosely correlated
-1.48%
KYMR - RVMD
54%
Loosely correlated
-3.48%
RARE - RVMD
52%
Loosely correlated
-2.43%
OCUL - RVMD
51%
Loosely correlated
-2.54%
More